5-(tert-Butoxy)-5-oxopentanoic acid, 95.0%, 100g

4-(Cyanomethyl)-3-fluorobenzonitrile, 95%, 250mg

Methyl 3-oxo-2,3-dihydropyridazine-4-carboxylate, 95.0%, 250mg

1-Boc-3-Hydroxy-4-methylenepiperidine, 95.0%, 25g

2-((2-CHLOROETHYL)AMINO)ETHANOL HCL, 95.0%, 250mg

2-Fluoro-5-(methoxymethoxy)phenylboronic acid, 97%, 1g

(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine, 95%, 25g

1-isobutyrylpiperidin-4-one, 95.0%, 10g

D(+)-raffinose pentahydrate, min. 98%, for biochemistry, 50 g, plastic packaging.

(4S,5S)-1,3-Bis(2-isopropoxyphenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 250mg

4-Bromo-2-nitronaphthalen-1-amine, 95.0%, 5g

3-Oxo-2-phenyl-2,3-dihydro-1H-isoindole-4-carboxylic acid, 50mg

Xanthohumol, >98%, 10mg